IPO Subscription Report
Goldline Pharmaceutical IPO Day 1 Subscription Report — 12 May 2026 | GMP ₹17 & Analysis
Goldline Pharmaceutical Ltd IPO opened 12 May 2026 on BSE SME. Read our Day 1 subscription analysis, GMP ₹17, category-wise status, company overview and what to expect on Day 2 and Day 3 before allotment.